Brussels, 07/01/2016 (Agence Europe) - The treatment of Ebola patients by using blood plasma from people cured of Ebola is possible. It does not present any risks and is acceptable to donors, patients and health professionals. Nonetheless, the treatment, as administered in a clinical trial, does not significantly improve the chances of a patient's survival.
These are the disappointing results from the Ebola-Tx clinical trial published on Thursday 7 January in the New England Journal of...